Rheumatoid Arthritis: Why Early Diagnosis Changes Everything

Rheumatoid arthritis is routinely confused with ordinary wear-and-tear arthritis, and the confusion costs joints. It is an autoimmune disease, it damages joints permanently within the first one to two years if untreated, and modern treatment can bring it into remission if started early.

How it differs from osteoarthritis

| | Rheumatoid arthritis | Osteoarthritis | |—|—|—| | Mechanism | Autoimmune inflammation of the joint lining | Mechanical cartilage and joint wear | | Age | Commonly 30 to 50, any age | Usually over 50 | | Morning stiffness | More than 30 to 60 minutes | Under 30 minutes | | Pattern | Symmetrical, both sides | Often asymmetrical | | Joints | Small joints of hands, wrists, feet first | Knees, hips, spine, finger end joints | | Effect of activity | Improves with movement | Worsens with use | | Systemic features | Fatigue, low fever, weight loss | None | | Swelling | Soft, warm, boggy | Bony, hard |

A useful distinguishing detail: rheumatoid arthritis typically spares the end joints of the fingers, those nearest the nails, while osteoarthritis frequently involves them.

Early symptoms

• Pain, swelling and warmth in the small joints of the hands, wrists and feet, usually on both sides
• Morning stiffness lasting more than an hour, easing as the day goes on
• Difficulty making a fist, opening jars, or turning a key in the morning
• Tenderness when the knuckles are squeezed together
• Profound fatigue, often preceding joint symptoms
• Low-grade fever, loss of appetite, weight loss
• Pain in the balls of the feet on first standing in the morning

Later, the disease can affect larger joints, and untreated it causes deformity, joint destruction and loss of function.

Beyond the joints

Rheumatoid arthritis is a systemic disease:

• Rheumatoid nodules, firm lumps over pressure points such as the elbows
• Dry eyes and dry mouth
• Interstitial lung disease
• Pleural effusion
• Anaemia of chronic disease
• Accelerated cardiovascular disease, which is the leading cause of death in RA, driven by chronic inflammation
• Osteoporosis, worsened by inflammation, inactivity and steroids
• Vasculitis in severe disease
• Cervical spine instability, which anaesthetists need to know about before any surgery

Diagnosis

• Rheumatoid factor: positive in about 70 to 80 percent, but also positive in other conditions and in some healthy people, so it is neither necessary nor sufficient
• Anti-CCP antibodies: more specific, often positive years before symptoms, and predict more aggressive disease
• ESR and CRP: inflammation markers that help track activity
• X-rays of hands and feet, which may be normal early
• Ultrasound or MRI, which detect inflammation and erosions earlier than X-ray
• Baseline blood count, liver and kidney function before treatment

Seronegative rheumatoid arthritis, with negative antibodies, exists and is diagnosed clinically. A negative test does not exclude the disease.

The treatment window

This is the central point. Joint erosion begins early, and damage is irreversible. Studies consistently show that starting disease-modifying treatment within the first three to six months of symptoms produces substantially better long-term outcomes than starting later. The phrase used is the window of opportunity.

Anyone with persistent swelling of small joints for more than six weeks with prolonged morning stiffness should be referred to a rheumatologist promptly, not managed with painkillers for a year.

Treatment

DMARDs, disease-modifying anti-rheumatic drugs, are the foundation:

• Methotrexate, the anchor drug, taken once weekly, never daily. Taking it daily by mistake causes severe toxicity. Folic acid is prescribed alongside to reduce side effects. Alcohol must be limited, pregnancy avoided in both partners for the recommended interval, and blood counts and liver function monitored regularly
• Sulfasalazine, leflunomide and hydroxychloroquine, used alone or in combination

Biologics and targeted therapies for inadequate response: TNF inhibitors, and agents targeting IL-6, B cells or T cell co-stimulation, plus oral JAK inhibitors. These require screening for tuberculosis and hepatitis B before starting, which is particularly important in India.

Steroids are used as a short bridge while DMARDs take effect, or for flares. Long-term steroid use causes diabetes, osteoporosis, cataract, infection and weight gain, and is avoided where possible.

NSAIDs relieve symptoms but do not alter the disease and do not prevent joint damage.

Non-drug management matters: regular exercise including both aerobic and strengthening work, physiotherapy, occupational therapy and joint protection techniques, smoking cessation which both triggers the disease and reduces treatment response, weight management, and cardiovascular risk control.

Monitoring

Expect regular disease activity scoring and blood monitoring, since DMARDs and biologics affect blood counts, liver and immune function. Report fever or infection promptly while on these drugs. Vaccination, including influenza and pneumococcal, is recommended, with live vaccines avoided on biologics.

Pregnancy

RA often improves during pregnancy and flares afterwards. Several drugs, including methotrexate and leflunomide, must be stopped well in advance. Plan pregnancy with your rheumatologist rather than stopping medication on discovering it.

This is general information. Persistent small-joint swelling with prolonged morning stiffness needs rheumatology assessment early; delay costs joint function that cannot be recovered.